Our Target Malaria consortium paper demonstrating how CRISPR-CAS9 can be used to drive disruption of female fertility genes is out now in Nature Biotechnology. A great job led by Tony Nolan in the Imperial College team.
Our Target Malaria consortium paper demonstrating how CRISPR-CAS9 can be used to drive disruption of female fertility genes is out now in Nature Biotechnology. A great job led by Tony Nolan in the Imperial College team. |